Similarly, in ESTA, metastatic SCC (84.2%) has a higher percentage of tissues with low‐Cdh23 expression compared with the SCC (72.6%) and normal esophageal mucosa adjacent to cancer (50%), further strengthening our observation of a decrease in Cdh23 expression during ESTA progression. The gene discussed is CDH23; the disease is cancer.